|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.56 EUR | -1.94% |
|
+8.90% | +117.68% |
| May. 15 | Jenoptik AG, Q1 2026 Earnings Call, May 12, 2026 | |
| May. 13 | Jenoptik: Jenoptik Q1 2026: Semiconductor momentum drives margin expansion | ![]() |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.2 | 4.37 | 5.34 | 5.4 | 4.22 | |||||
Return on Total Capital | 4.24 | 5.43 | 6.43 | 6.47 | 5.05 | |||||
Return On Equity % | 12.63 | 7.86 | 8.45 | 9.9 | 7.2 | |||||
Return on Common Equity | 12.52 | 7.74 | 8.43 | 9.8 | 7.02 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 34.22 | 35.25 | 34.76 | 33.44 | 32.15 | |||||
SG&A Margin | 19.08 | 17.65 | 15.86 | 14.86 | 15.85 | |||||
EBITDA Margin % | 16.17 | 17.98 | 18.6 | 18.34 | 16.9 | |||||
EBITA Margin % | 12.61 | 15.3 | 15.77 | 15.35 | 13.2 | |||||
EBIT Margin % | 10.56 | 12.22 | 13.38 | 13.18 | 11.03 | |||||
Income From Continuing Operations Margin % | 12.37 | 6.51 | 6.92 | 8.3 | 6.8 | |||||
Net Income Margin % | 10.92 | 5.62 | 6.8 | 8.3 | 6.88 | |||||
Net Avail. For Common Margin % | 12.06 | 6.31 | 6.83 | 8.16 | 6.59 | |||||
Normalized Net Income Margin | 5.91 | 6.98 | 7.29 | 7.22 | 5.86 | |||||
Levered Free Cash Flow Margin | -10.02 | 8.54 | 4.27 | 4.54 | 6.73 | |||||
Unlevered Free Cash Flow Margin | -9.4 | 9.66 | 5.53 | 5.79 | 8.13 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.48 | 0.57 | 0.64 | 0.66 | 0.61 | |||||
Fixed Assets Turnover | 2.83 | 3.32 | 3.11 | 2.84 | 2.47 | |||||
Receivables Turnover (Average Receivables) | 3.6 | 4.89 | 5.18 | 5.16 | 4.84 | |||||
Inventory Turnover (Average Inventory) | 2.52 | 2.78 | 2.65 | 2.77 | 2.82 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.37 | 1.76 | 2.07 | 2.26 | 1.6 | |||||
Quick Ratio | 0.61 | 0.92 | 1.07 | 1.22 | 0.9 | |||||
Operating Cash Flow to Current Liabilities | 0.21 | 0.46 | 0.61 | 0.64 | 0.57 | |||||
Days Sales Outstanding (Average Receivables) | 101.27 | 74.63 | 70.48 | 70.93 | 75.46 | |||||
Days Outstanding Inventory (Average Inventory) | 144.73 | 131.11 | 137.81 | 132.15 | 129.5 | |||||
Average Days Payable Outstanding | 66.8 | 51.47 | 53.92 | 52.99 | 52.96 | |||||
Cash Conversion Cycle (Average Days) | 179.2 | 154.26 | 154.37 | 150.08 | 152 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 76.57 | 63.65 | 54.33 | 49.74 | 39.74 | |||||
Total Debt / Total Capital | 43.36 | 38.89 | 35.2 | 33.22 | 28.44 | |||||
LT Debt/Equity | 57.48 | 56.65 | 51.64 | 47.96 | 27.14 | |||||
Long-Term Debt / Total Capital | 32.56 | 34.62 | 33.46 | 32.03 | 19.42 | |||||
Total Liabilities / Total Assets | 55.57 | 49.56 | 45.81 | 44.41 | 39.78 | |||||
EBIT / Interest Expense | 10.5 | 6.84 | 6.65 | 6.55 | 4.9 | |||||
EBITDA / Interest Expense | 17.64 | 10.7 | 9.9 | 9.8 | 8.08 | |||||
(EBITDA - Capex) / Interest Expense | 13.63 | 7.02 | 6.24 | 6.09 | 5.35 | |||||
Total Debt / EBITDA | 4.49 | 2.86 | 2.31 | 2.19 | 2.11 | |||||
Net Debt / EBITDA | 4.06 | 2.56 | 1.99 | 1.8 | 1.67 | |||||
Total Debt / (EBITDA - Capex) | 5.8 | 4.37 | 3.67 | 3.51 | 3.19 | |||||
Net Debt / (EBITDA - Capex) | 5.25 | 3.9 | 3.16 | 2.89 | 2.52 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 21.98 | 30.63 | 8.7 | 4.67 | -6.26 | |||||
Gross Profit, 1 Yr. Growth % | 14.31 | 34.57 | 7.18 | 0.71 | -9.88 | |||||
EBITDA, 1 Yr. Growth % | 8.61 | 46.08 | 12.44 | 2.88 | -14 | |||||
EBITA, 1 Yr. Growth % | 23.78 | 53.38 | 12.06 | 1.54 | -19.87 | |||||
EBIT, 1 Yr. Growth % | 30.26 | 51.06 | 19.09 | 2.64 | -22.04 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 172.83 | -31.24 | 15.6 | 25.45 | -23.17 | |||||
Net Income, 1 Yr. Growth % | 96.31 | -32.8 | 31.52 | 27.85 | -22.28 | |||||
Normalized Net Income, 1 Yr. Growth % | 34.21 | 54.32 | 13.43 | 3.34 | -24.37 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 173.69 | -31.6 | 17.6 | 24.97 | -24.27 | |||||
Accounts Receivable, 1 Yr. Growth % | -5.02 | -2.37 | 7.8 | 2.5 | -2.44 | |||||
Inventory, 1 Yr. Growth % | 4.6 | 27.84 | 5.2 | -0.84 | -11.39 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 1.2 | 21.73 | 11.41 | 15.01 | 1.5 | |||||
Total Assets, 1 Yr. Growth % | 31.24 | -4.85 | -0.29 | 4.39 | -3.65 | |||||
Tangible Book Value, 1 Yr. Growth % | -88.02 | 367.29 | 74.44 | 44.7 | 24.2 | |||||
Common Equity, 1 Yr. Growth % | 13.28 | 8.35 | 7.77 | 7.11 | 4.43 | |||||
Cash From Operations, 1 Yr. Growth % | 9.18 | 45.68 | 17.02 | 0.08 | 17.3 | |||||
Capital Expenditures, 1 Yr. Growth % | 14.12 | 113.26 | 21.98 | 5.85 | -22.65 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -248.9 | -209.78 | -45.6 | 10.16 | 37.36 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -230.12 | -234.24 | -37.72 | 8.92 | 30.36 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 20 | 16.67 | 8.57 | 5.26 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -6.31 | 26.23 | 19.17 | 6.67 | -0.95 | |||||
Gross Profit, 2 Yr. CAGR % | -6.17 | 24.02 | 20.09 | 3.89 | -4.73 | |||||
EBITDA, 2 Yr. CAGR % | -1.54 | 25.61 | 28.16 | 7.72 | -5.72 | |||||
EBITA, 2 Yr. CAGR % | -3.98 | 40.05 | 31.1 | 6.87 | -9.54 | |||||
EBIT, 2 Yr. CAGR % | -7.11 | 40.27 | 34.13 | 10.8 | -10.26 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 17.17 | 36.97 | -10.84 | 20.42 | -1.83 | |||||
Net Income, 2 Yr. CAGR % | 10.09 | 14.85 | -5.99 | 29.67 | -0.32 | |||||
Normalized Net Income, 2 Yr. CAGR % | -9.5 | 43.98 | 32.31 | 8.48 | -11.31 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 15.67 | 36.83 | -10.31 | 21.23 | -2.72 | |||||
Accounts Receivable, 2 Yr. CAGR % | 2.65 | -3.7 | 2.59 | 5.12 | -0 | |||||
Inventory, 2 Yr. CAGR % | 14.14 | 15.64 | 15.97 | 2.14 | -6.26 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 3.05 | 10.99 | 16.46 | 13.74 | 8.04 | |||||
Total Assets, 2 Yr. CAGR % | 27.35 | 11.74 | -2.6 | 2.02 | 0.29 | |||||
Tangible Book Value, 2 Yr. CAGR % | -76.6 | -25.19 | 185.51 | 58.88 | 34.06 | |||||
Common Equity, 2 Yr. CAGR % | 8.29 | 10.79 | 8.06 | 7.44 | 5.76 | |||||
Cash From Operations, 2 Yr. CAGR % | -5.14 | 26.12 | 30.54 | 8.22 | 8.35 | |||||
Capital Expenditures, 2 Yr. CAGR % | -4.97 | 56 | 61.29 | 13.63 | -9.52 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 26.58 | 28.72 | -22.72 | -22.25 | 23.74 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 18.89 | 32.16 | -8.57 | -17.36 | 19.71 | |||||
Dividend Per Share, 2 Yr. CAGR % | 38.68 | 9.54 | 18.32 | 12.55 | 6.9 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -3.47 | 4.67 | 20.09 | 14.12 | 2.17 | |||||
Gross Profit, 3 Yr. CAGR % | -4.3 | 5.81 | 18.13 | 13.25 | -0.92 | |||||
EBITDA, 3 Yr. CAGR % | -1.65 | 12.09 | 21.06 | 19.24 | 0.09 | |||||
EBITA, 3 Yr. CAGR % | -3.68 | 13.47 | 30.02 | 20.55 | -2.73 | |||||
EBIT, 3 Yr. CAGR % | -6.56 | 9.24 | 32.82 | 22.86 | -1.24 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 2.03 | -1.9 | 29.44 | -0.09 | 3.67 | |||||
Net Income, 3 Yr. CAGR % | -2.17 | -6.61 | 20.16 | 4.15 | 9.33 | |||||
Normalized Net Income, 3 Yr. CAGR % | -9.54 | 8.15 | 32.98 | 22.01 | -3.6 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 1.11 | -2.91 | 30.09 | 0.18 | 3.63 | |||||
Accounts Receivable, 3 Yr. CAGR % | 9.49 | 0.95 | -0.01 | 2.56 | 2.54 | |||||
Inventory, 3 Yr. CAGR % | 4.47 | 18.54 | 12.05 | 10.07 | -2.59 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 12.77 | 8.93 | 11.13 | 16.34 | 9.5 | |||||
Total Assets, 3 Yr. CAGR % | 21.24 | 15.56 | 7.58 | -0.32 | 0.1 | |||||
Tangible Book Value, 3 Yr. CAGR % | -60.35 | -36.51 | -0.8 | 127.63 | 46.36 | |||||
Common Equity, 3 Yr. CAGR % | 8.73 | 8.31 | 9.78 | 7.74 | 6.43 | |||||
Cash From Operations, 3 Yr. CAGR % | -10.24 | 9.45 | 23 | 19.48 | 11.16 | |||||
Capital Expenditures, 3 Yr. CAGR % | -6.15 | 24.42 | 43.72 | 40.16 | -0.04 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 15.36 | 21.25 | -3.4 | -12.78 | -5.64 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 11.05 | 23.8 | 2.85 | -2.86 | -3.51 | |||||
Dividend Per Share, 3 Yr. CAGR % | -10.61 | 32.15 | 11.87 | 14.98 | 10.06 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.86 | 5.57 | 5.02 | 5.46 | 11.19 | |||||
Gross Profit, 5 Yr. CAGR % | 1.55 | 5.55 | 4.8 | 5.04 | 8.39 | |||||
EBITDA, 5 Yr. CAGR % | 5.26 | 9.8 | 9.21 | 10.32 | 9.61 | |||||
EBITA, 5 Yr. CAGR % | 5.37 | 10.96 | 9.67 | 10.78 | 12.54 | |||||
EBIT, 5 Yr. CAGR % | 3.5 | 7.81 | 7.98 | 9.86 | 13.64 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 11.49 | -2.55 | -3.33 | 6.48 | 15.89 | |||||
Net Income, 5 Yr. CAGR % | 7.39 | -5.34 | -3.72 | 6.49 | 11.51 | |||||
Normalized Net Income, 5 Yr. CAGR % | 2.61 | 6.25 | 5.34 | 8.29 | 13.18 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 10.94 | -3.11 | -3.62 | 6.11 | 15.81 | |||||
Accounts Receivable, 5 Yr. CAGR % | 9.26 | 7.76 | 6.68 | 2.59 | -0.01 | |||||
Inventory, 5 Yr. CAGR % | 4.67 | 8.7 | 8.93 | 11.68 | 4.33 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 11.05 | 14.53 | 14.23 | 10.83 | 10.09 | |||||
Total Assets, 5 Yr. CAGR % | 16.66 | 13.46 | 11.07 | 9.94 | 4.6 | |||||
Tangible Book Value, 5 Yr. CAGR % | -41.77 | -22.5 | -12.66 | -8.37 | 11.9 | |||||
Common Equity, 5 Yr. CAGR % | 10 | 9.44 | 8.46 | 7.96 | 8.15 | |||||
Cash From Operations, 5 Yr. CAGR % | -0.43 | 8.18 | 4.27 | 8.94 | 16.91 | |||||
Capital Expenditures, 5 Yr. CAGR % | 3.31 | 16.27 | 16.55 | 19.98 | 19.44 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 8.31 | 11.91 | -1.45 | 1.51 | 6.84 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 5.84 | 13.56 | 2.74 | 5.32 | 9.43 | |||||
Dividend Per Share, 5 Yr. CAGR % | 0 | 0 | 0 | 23.93 | 9.86 |
- Stock Market
- Equities
- JEN Stock
- Financials Jenoptik AG
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

















